Headlands Technologies’s GeoVax Labs GOVX Stock Holding History

Headlands Technologies’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$124	–	1296
2024 Q4	$124	Buy	+2	New	+$116	﹤0.01%	1153

Other funds holding GOVX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Headlands Technologies's GOVX Position: Q1 2025 in Review

Headlands Technologies sold out of GeoVax Labs (GOVX) in Q1 2025, closing a stake of 2 shares — an estimated $124 sold.

Headlands Technologies first reported a position in GOVX in Q4 2024 and held it in 1 quarter. The position peaked at $124 in Q4 2024. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2025.

Headlands Technologies reported no remaining GeoVax Labs position as of Q1 2025 after selling out during the quarter.
Headlands Technologies sold 2 GeoVax Labs shares in Q1 2025, an estimated $124.
Headlands Technologies first reported a position in GeoVax Labs in Q4 2024 and held it in 1 quarter.
Headlands Technologies's GeoVax Labs position peaked at $124 in Q4 2024.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2025.

Based on Headlands Technologies's 13F filing for Q1 2025, filed 9 May 2025.